Bozkurt, MehtapÇağlayan, MehmetUçar, DemetOktayoğlu, PelinEm, SerdaGün, RamazanGür, AliNas, Kemal2023-11-032023-11-032014Bozkurt, M., Çağlayan, M., Uçar, D., Oktayoğlu, P., Em, S., Gün, R. ve diğerleri. (2014). Evaluation of hearing loss in patients with ankylosing spondylitis. Erciyes Tıp Dergisi, 36(3), 119-122.1300-199Xhttps://jag.journalagent.com/cpr/pdfs/EMJ_36_3_119_122.pdfhttps://hdl.handle.net/11468/13042Materials and Methods: A total of 50 AS patients and 34 healthy controls were enrolled into the study. Physical examinations and disease activity score measurements were performed in patients with AS. Results: The mean age was 32.20 years (18-55) in AS patients and 35.58 (20-50) in the control group. The mean disease duration was 5.27 years (0-22) in patients with AS. Hearing loss was detected in seven (14%) of the AS patients and three (8.8%) of the control patients. In terms of hearing loss, a statistically signifcant difference was not found between the two groups. Sensorineural hearing loss was the most commonly detected type of hearing loss in the two groups. Hearing loss was present in two (28.5%) of the seven AS patients in whom the duration of disease was more than 10 years. There was no statistically signifcant correlation between the duration of disease and hearing loss. Conclusion: There was no signifcant difference between the AS and control groups with respect to hearing loss. The rate of hearing loss increased in line with the duration of disease. Objective: The aim of this study was to evaluate the rate of hearing loss in patients with ankylosing spondylitis (AS) and to analyze whether the rates of hearing loss were different from the control group or not.eninfo:eu-repo/semantics/openAccessAnkylosing spondylitisDisease durationHearing lossArticle363119122WOS:0004212508000052-s2.0-8490797843216258710.5152/etd.2014.7024N/AN/A